Skip to main content

Lɛ wi tɔk bɔt liva kansa (Hepatocellular Carcinoma - HCC) insay simpul wɔd dɛn?

Lɛ wi tɔk bɔt liva kansa (Hepatocellular Carcinoma - HCC) insay simpul wɔd dɛn?

Yu dɔn ɛva fil se yu ebi, yu gɛt smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl. Sɔntɛnde, dɛn tin ya kin bi jɔs nɔmal gas pen. Bɔt sɔntɛnde, dɛn kin bi sayn fɔ wan siriɔs sik na di liva, we na wan pan di impɔtant pat dɛn na wi bɔdi. Tide wi de tɔk bɔt Hepatocellular Carcinoma (HCC), we na di kayn kansa we kin apin pas ɔl na di liva. Pan ɔl we dis nem kin tan lɛk se i de mek pɔsin fred smɔl ɛn i kɔmplikt we yu yɛri am, nɔ wɔri. Lɛ wi tɔk bɔt dis simpul we we ɔlman go ɔndastand.

Wetin na dis Ɛpatosɛlular Karsinɔma (HCC)?

Fɔ tɔk am simpul wan, HCC na di kayn kansa we kin bigin na di liva sɛl dɛn. Na wan kayn kansa we nɔ kin rili bad. Bɔrku tɛm, dɛn kin si am pan pipul dɛm wae dɔn ɔlrɛdi gɛt wan sik wae nɔr de mɛn na dɛn liva, mɔr lɛk sirosis , we na wan sik we de mek di liva kin stif ɛn gɛt skata, ɛn i nɔ kin wok fayn. Dis biɛn tɛm, dɛn dɔn si HCC bak mɔ pan pipul dɛn we gɛt mɛtabolik disfɔkshɔn-associated steatotic liver disease (MASLD), we na wan kɔndishɔn we kin kam bikɔs di fat kin gɛda na di liva.

Wan pan de tin wae de mek wi fil bad bɔt dis kansa na dat e kin gro sloslo we i bigin. So, nɔr kin gɛt ɛni sayn fɔ de na di fɔs stej. I kin mɛn insay di fɔs stej bay we dɛn du ɔpreshɔn fɔ pul di tumbu ɔ bay we dɛn transplant di liva. Bɔt bay di tɛm we dɛn kin no se bɔku pipul dɛn gɛt dis sik, di kansa dɔn ɔlrɛdi skata ɛn i kin rich wan stej we i kin skata kwik kwik wan. As tɛm de go, dis kin ivin mek di liva nɔ wok fayn. If na so i bi, fɔ trit dɔktɔ dɛn kin rili tranga.

Dis sik so siriɔs dat if yu gɛt liva sik lɛk sirosis ɔ MASLD, yu dɔktɔ go mɔs de chɛk yu ɔltɛm fɔ si if yu gɛt ɛni sayn fɔ HCC kansa.

Aw kɔmɔn dis kansa?

Tink bɔt dis: 85 to 90 pan 100 praymari kansa dɛn na di liva na HCC. (We kansa pas ɔdasay na di liva, wi kin kɔl am mɛtastatik kansa.) Na di nɔmba siks kansa we dɛn kin gɛt pas ɔl na di wɔl ɛn na di tɔd tin we kin mek pipul dɛn day wit kansa.

Wetin pas dat, man dɛn kin gɛt dis sik tu to tri tɛm pas uman dɛn. Bɔrku tɛm, pipul dɛm wae dɛn kin no se gɛt dis sik kin ol 60 ia ɔr pas dat.

Wetin na di sayn dɛm fɔ HCC?

As wi bin dɔn tɔk, kansa tumbu nɔ kin mek pɔsin gɛt ɛni sayn we i bigin. Bɔt as di kansa de go bifo, yu kin bigin fɔ gɛt tin dɛn lɛk:

Di sayn we de sho se di sik de Fɔ tɔk am simpul wan...
Fulnɛs ɔnda di rayt rib kech Fɔ fil se yu ebi ɔ yu gɛt smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl .
Fulnɛs ɔnda di lɛft rib kech filin fכ hεvi כnda di rib dεm na di lεft sayd (dis kin bi sayn f כ di spεlin we big ).
Di skin ɛn di yay dɛn we de yɔlɔ Wi kin kɔl dis janda .
Di bɛlɛ we de blo Wan filin we de swel lɛk se di bɛlɛ ful-ɔp wit wata.
Fil fɔ it Nɔ fil fɔ it, fil ful ivin afta yu it smɔl.
We yu de lɔs yu wet Fɔ lɔs yu wet fɔ no rizin.
Nɔs ɛn vɔmit Nɔs ɛn vɔmit we de kɔntinyu fɔ de.
Skin we de it Wan it we pɔsin kin it ɔltɛm ɔlsay na di bɔdi ɔ na sɔm say dɛn.

Bɔt mɛmba dis. Bɔrku tɛm yu kin si dɛn sayn ya pan ɔda kɔmɔn sik dɛm bak. So nɔ panik jɔs bikɔs yu gɛt wan ɔ tu pan dɛn tin ya. Bɔt if dɛn sik ya kɔntinyu fɔ pas tu wiks, i go fayn fɔ mek yu go to dɔktɔ ɛn chɛk yu.

Wetin mek HCC kansa kin kam? Wetin na di tin dɛn we kin mek pɔsin gɛt dis sik?

Bɔrku pipul dɛm wae dɛn no se gɛt HCC (lɛk 80%) gɛt sirosis. Sɔm pipul dɛn kin gɛt dis kansa bifo dɛn gɛt sirosis. Insay dɛn kɔndishɔn ya, if dɛn nɔ trit am, di inflamɛns we nɔ de dɔn na di liva kin mek di liva gɛt siriɔs skata, we kin mek i gɛt HCC.

Bɔku impɔtant tin dɛn de we kin mek yu gɛt mɔ chans fɔ gɛt HCC kansa.

Risk factor Aw dis kin afɛkt?
Epataytis B infεkshכn Wan vayral infεkshכn de spre tru di bכdi wata. Di spɛshal tin bɔt dis na dat i kin mek HCC kansa ivin bifo sirosis apin.
Epataytis C infεkshכn Wan vayral infεkshכn we de spre tru di blɔd. Dis kin pwɛl di liva bak ɛn i kin mek pɔsin gɛt kansa mɔ ɛn mɔ.
Fat liva sik (MASLD) . Fat we nɔ want fɔ gɛda na di liva. Dis risk kin pasmak if yu gɛt fat, mɛtabolik sindrom, ɔ tayp 2 dayabitis.
Fɔ drink rɔm pasmakAlkol na tin we at fɔ mek wi liva swɛla. If yu drink pasmak fɔ lɔng tɛm, dat kin pwɛl yu liva, ɛn dis kin mek yu gɛt sirosis ɛn kansa na yu liva.

If yu de na dis risk grup, yu dɔktɔ go de chɛk yu ɔltɛm fɔ si if yu gɛt sayn dɛn fɔ dis kansa. Dis kin ɛp fɔ no di sik kwik kwik wan ɛn trit am. Yu dɔktɔ go ɛp yu bak fɔ stɔp fɔ smok ɔ drink rɔm, ɛn fɔ kɔntrol sik dɛn we nɔ de mɛn lɛk epataytis infɛkshɔn ɛn dayabitis.

Aw dɛn kin no dis sik kɔrɛkt wan?

We yu go to dɔktɔ, i go fɔs chɛk yu bɔdi ɛn aks yu bɔt di sayn dɛn we yu gɛt, di mɛdikal istri, ɛn aw yu de liv yu layf. Dɔn, dɛn kin du bɔku tɛst fɔ no if dɛn gɛt di sik, lɛk:

  • Blɔd tɛst: Dɛn go chɛk yu blɔd fɔ si if yu gɛt sayn dɛn fɔ gɛt kansa. spεshal wan, dεn go chεk di lεvεl fכ wan protin we dεn kכl alfa-fεtoprotein (AFP) . If dis lɛvɛl go ɔp, i kin bi sayn fɔ HCC ɔ wan kɔndishɔn we kin mek pɔsin gɛt am, lɛk epataytis ɔ sirosis.
  • Imej skan: Skan lɛk ɔltra saund, kɔmpyuta tomografi (CT) skan, magnɛtik rɛsɔnans imej (MRI) , ɔ angiografi kin sho klia wan di kwaliti dɛn we di tumbu ɔ di tɔŋ dɛn we de insay di liva gɛt.
  • Liva bayɔpsi: Sɔntɛnde, if di skan rizɔlt nɔto inof infɔmeshɔn, di dɔktɔ go tek wan rili smɔl tisu frɔm di liva tumbu ɛn chɛk am ɔnda maykroskɔp fɔ si if ɛni kansa sɛl de. Bɔt wan pan di spɛshal tin dɛn we HCC gɛt na dat if yu si di tumbu klia wan pan MRI ɔ CT skan fɔ pɔsin we gɛt sirosis, dɛn kin no di sik we dɛn nɔ tek bayɔpsi .

Wetin na di tritmɛnt dɛm fɔ HCC?

Di tritmɛnt fɔ HCC dipen pan di stej we di kansa de, di ɔl wɛlbɔdi na di liva, ɛn yu jenɛral wɛlbɔdi. Bɔku men tritmɛnt dɛn de we yu kin gɛt.

Di we aw dɛn kin trit am Wan simpul ɛksplen
ƆpreshɔnDɛn kin du ɛpatektomi (dɛn kin pul di pat pan di liva usay di kansa de) ɔ dɛn kin du liva transplant (liva transplant) . Dis kin bi na di fɔs stej dɛm fɔ di sik.
Ablashɔn tɛrapi di kansa sel dεm kin pwεl bay we dεn de bכn dεm wit bכku כt (maykrowev כ rediofrikyuεns wev) כ we dεn kol pasmak we dεn de yuz spεshal nidul.
Embolization Di blɔd vesel dɛn we de gi blɔd to di tumbu kin blok. Sɔntɛnde dɛn kin sɛn mɛrɛsin dɛn we de fɛt kansa (chemoembolization) ɔ smɔl smɔl redioaktiv sid dɛn (redioemboliization) tru dɛn wan ya.
Redyushɔn tɛrapi Smɔl tumbu dɛn we dɛn nɔ go ebul fɔ pul bay ɔpreshɔn, dɛn kin pwɛl dɛn bay we dɛn de yuz raytin we gɛt bɔku ɛnaji. SBRT (Stereotactic body radiation therapy) na spɛshal we we dɛn kin yuz fɔ dis.
Imyunotɛrapi Wi de gi drɔgs we de mek wi bɔdi in yon imyun sistɛm wok, we de mek i no ɛn atak di kansa sɛl dɛn.
Targeted therapy Dɛn kin gi spɛshal mɛrɛsin dɛn we de blok di sayn dɛn we de mek di kansa sɛl dɛn gro ɛn sheb.

Yu dɔktɔ kin tɛl yu bak fɔ tek pat pan klinik trial dɛn we de tɛst nyu tritmɛnt dɛn. Dɛn kin gi yu bak palliative care fɔ ɛp fɔ kɔntrol di sayn dɛm, fɔ ridyus yu diskɔmfɔt, ɛn mek yu layf izi.

Yu tink se dɛn go ebul fɔ mɛn dis sik kpatakpata?

Ɔpreshɔn fɔ pul di tumbu ɔ fɔ transplant di liva na di bɛst tin fɔ mek i wɛl kɔmplit wan. Ivin if i nɔ pɔsibul fɔ mek yu du ɔpreshɔn, ɔda tritmɛnt dɛn de we go mek yu nɔ gɛt di sik, mek di kansa nɔ gro sloslo, ɛn ɛp yu fɔ liv lɔng.

Akɔdin to sɔm statystik, di fayv ia sɔvayv rɛt fɔ pipul dɛm wae gɛt dis sik na 21% nɔmɔ. Bɔt nɔ mek yu fred fɔ dis. Dis nɔto di sem tin fɔ ɔlman. E kin difrɛn bad bad wan fɔ yu sik, aw yu gɛt di kansa, aw yu liva gɛt wɛl bɔdi, ɛn aw yu de du tritmɛnt. Ɛni sikman difrɛn. So, na yu dɔktɔ nɔmɔ go ebul fɔ gi yu di bɛst aidia bɔt wetin fɔ ɛkspɛkt bay di sik we yu gɛt.

Wetin wi kin du fɔ mek wi nɔ gɛt HCC kansa?

Bɔrku tin de wae yu kin du fɔ ridyus yu risk fɔ gɛt dis kansa:

  • Gɛt di vaysin agens Epataytis B. If yu dɔn ɔlrɛdi gɛt di sik, go de chɛk yu ɔltɛm wit dɔktɔ.
  • If yu tink se yu dɔn gɛt Epatitis C, go to dɔktɔ wantɛm wantɛm. Dis na sik we dɛn kin mɛn naw wit mɛrɛsin.
  • Kɔntrol kɔndishɔn dɛn we gɛt fɔ du wit fat liva sik (MASLD). I rili impɔtant fɔ kɔntrol yu bɔdi wet bay we yu de it fayn ɛn ɛksesaiz.
  • Nɔ drink rɔm pasmak kpatakpata.
  • If yu de smok, stɔp wantɛm wantɛm.

Ustɛm a fɔ go to dɔktɔ? Us kwɛstyɔn dɛn a fɔ aks?

If yu gɛt de sik wae wi dɔn tɔk bɔt fɔ pas tu wiks, ɔr if yu sik de wɔs, go to dɔktɔ kwik kwik wan. If yu de na grup we gɛt prɔblɛm, nɔ skip di tɛst dɛn we yu dɔktɔ tɛl yu fɔ du. Mɛmba se, di mɔ we dɛn no dis sik kwik kwik wan, na di mɔ i go izi fɔ mek dɛn trit am fayn.

Na sɔm impɔtant kwɛstyɔn dɛn we yu fɔ aks yu dɔktɔ:

* Aw mi liva de wok fayn?

* Us stej mi kansa de insay?

* Yu tink se dis kin mɛn kpatakpata?

* Us tritmɛnt dɛn a gɛt?

* Wetin na di bad tin dɛn we kin apin to ɛni tritmɛnt?

* Aw tritmɛnt go afɛkt mi ɛvride layf?

* Aw wi go no if di tritmɛnt de wok fayn?

Na nɔmal tin fɔ fil frayd, wɔri, ɛn kɔnfyus we yu lan bɔt siriɔs sik lɛk HCC. Bɔt nɔto yu wan de na dis waka. Ɔndastand yu tritmɛnt dɛm ɛn di sayd ɛfɛkt dɛm we dɛn kin gɛt. Tɔk opin wan wit yu famili, padi dɛn, ɛn dɔktɔ. Dis kin tranga fɔ waka, bɔt if yu no di rayt tin, sɔpɔt yu, ɛn trit yu, yu go ebul fɔ bia wit di prɔblɛm.

Mɛsej we dɛn kin kɛr go na os

  • Epatocellular carcinoma (HCC) na di kayn kansa we de kכmכn pas כl εn we de gro fast fast.
  • Dis sik kin apun bɔrku tɛm pan pipul dɛm wae dɔn ɔlrɛdi gɛt liva sik, mɔr lɛk sirosis.
  • Yu fɔ no bɔt di sayn dɛm lɛk fɔ ebi ɔnda yu rayt rib, fɔ gɛt janda, fɔ swel na yu bɛlɛ, ɛn fɔ lɛf fɔ it bɔku bɔku it. If dɛn tin ya de fɔ pas tu wiks, go to dɔktɔ.
  • Epataytis B/C, fɔ drink pasmak, ɛn fɔ gɛt fat liva sik (MASLD) na di men tin dɛn we kin mek pɔsin gɛt dis sik.
  • If dɛn no di sik kwik kwik wan, dɛn kin ebul fɔ wɛl kɔmplit wan bay we dɛn du ɔpreshɔn ɔ transplant di liva.
  • If yu gɛt ɛni dawt ɔ kwɛstyɔn bɔt dis, nɔ ɛva ignore am. I rili impɔtant fɔ tɔk to yu dɔktɔ opin wan.

Hepatocellular Carcinoma, HCC, liva kansa Sinhala, Sirosis, Epataytis B, Liva simptom dɛm

Frequently Asked Questions (FAQ)

Aw kɔmɔn dis kansa?

Tink bɔt dis: 85 to 90 pan 100 praymari kansa dɛn na di liva na HCC. (We kansa pas ɔdasay na di liva, wi kin kɔl am mɛtastatik kansa.) Na di nɔmba siks kansa we dɛn kin gɛt pas ɔl na di wɔl ɛn na di tɔd tin we kin mek pipul dɛn day wit kansa.

⚠️ Important: The medical articles and information on Nirogi Lanka are for general awareness only, and are by no means a substitute for professional medical advice, diagnosis, or treatment. For any medical problem you have, consult a qualified physician immediately.

💬 Comments (0)

No kɔmɛnt nɔ de yet. Ad yu kɔmɛnt ya fɔ di fɔs tɛm.

Ad yu kɔmɛnt

Duya kɔlkul: 3 + 7 =
Lɛ wi tɔk bɔt liva kansa (Hepatocellular Carcinoma - HCC) insay simpul wɔd dɛn?

Lɛ wi tɔk bɔt liva kansa (Hepatocellular Carcinoma - HCC) insay simpul wɔd dɛn?

Yu dɔn ɛva fil se yu ebi, yu gɛt smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl. Sɔntɛnde, dɛn tin ya kin bi jɔs nɔmal gas pen. Bɔt sɔntɛnde, dɛn kin bi sayn fɔ wan siriɔs sik na di liva, we na wan pan di impɔtant pat dɛn na wi bɔdi. Tide wi de tɔk bɔt Hepatocellular Carcinoma (HCC), we na di kayn kansa we kin apin pas ɔl na di liva. Pan ɔl we dis nem kin tan lɛk se i de mek pɔsin fred smɔl ɛn i kɔmplikt we yu yɛri am, nɔ wɔri. Lɛ wi tɔk bɔt dis simpul we we ɔlman go ɔndastand.

Wetin na dis Ɛpatosɛlular Karsinɔma (HCC)?

Fɔ tɔk am simpul wan, HCC na di kayn kansa we kin bigin na di liva sɛl dɛn. Na wan kayn kansa we nɔ kin rili bad. Bɔrku tɛm, dɛn kin si am pan pipul dɛm wae dɔn ɔlrɛdi gɛt wan sik wae nɔr de mɛn na dɛn liva, mɔr lɛk sirosis , we na wan sik we de mek di liva kin stif ɛn gɛt skata, ɛn i nɔ kin wok fayn. Dis biɛn tɛm, dɛn dɔn si HCC bak mɔ pan pipul dɛn we gɛt mɛtabolik disfɔkshɔn-associated steatotic liver disease (MASLD), we na wan kɔndishɔn we kin kam bikɔs di fat kin gɛda na di liva.

Wan pan de tin wae de mek wi fil bad bɔt dis kansa na dat e kin gro sloslo we i bigin. So, nɔr kin gɛt ɛni sayn fɔ de na di fɔs stej. I kin mɛn insay di fɔs stej bay we dɛn du ɔpreshɔn fɔ pul di tumbu ɔ bay we dɛn transplant di liva. Bɔt bay di tɛm we dɛn kin no se bɔku pipul dɛn gɛt dis sik, di kansa dɔn ɔlrɛdi skata ɛn i kin rich wan stej we i kin skata kwik kwik wan. As tɛm de go, dis kin ivin mek di liva nɔ wok fayn. If na so i bi, fɔ trit dɔktɔ dɛn kin rili tranga.

Dis sik so siriɔs dat if yu gɛt liva sik lɛk sirosis ɔ MASLD, yu dɔktɔ go mɔs de chɛk yu ɔltɛm fɔ si if yu gɛt ɛni sayn fɔ HCC kansa.

Aw kɔmɔn dis kansa?

Tink bɔt dis: 85 to 90 pan 100 praymari kansa dɛn na di liva na HCC. (We kansa pas ɔdasay na di liva, wi kin kɔl am mɛtastatik kansa.) Na di nɔmba siks kansa we dɛn kin gɛt pas ɔl na di wɔl ɛn na di tɔd tin we kin mek pipul dɛn day wit kansa.

Wetin pas dat, man dɛn kin gɛt dis sik tu to tri tɛm pas uman dɛn. Bɔrku tɛm, pipul dɛm wae dɛn kin no se gɛt dis sik kin ol 60 ia ɔr pas dat.

Wetin na di sayn dɛm fɔ HCC?

As wi bin dɔn tɔk, kansa tumbu nɔ kin mek pɔsin gɛt ɛni sayn we i bigin. Bɔt as di kansa de go bifo, yu kin bigin fɔ gɛt tin dɛn lɛk:

Di sayn we de sho se di sik de Fɔ tɔk am simpul wan...
Fulnɛs ɔnda di rayt rib kech Fɔ fil se yu ebi ɔ yu gɛt smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl smɔl .
Fulnɛs ɔnda di lɛft rib kech filin fכ hεvi כnda di rib dεm na di lεft sayd (dis kin bi sayn f כ di spεlin we big ).
Di skin ɛn di yay dɛn we de yɔlɔ Wi kin kɔl dis janda .
Di bɛlɛ we de blo Wan filin we de swel lɛk se di bɛlɛ ful-ɔp wit wata.
Fil fɔ it Nɔ fil fɔ it, fil ful ivin afta yu it smɔl.
We yu de lɔs yu wet Fɔ lɔs yu wet fɔ no rizin.
Nɔs ɛn vɔmit Nɔs ɛn vɔmit we de kɔntinyu fɔ de.
Skin we de it Wan it we pɔsin kin it ɔltɛm ɔlsay na di bɔdi ɔ na sɔm say dɛn.

Bɔt mɛmba dis. Bɔrku tɛm yu kin si dɛn sayn ya pan ɔda kɔmɔn sik dɛm bak. So nɔ panik jɔs bikɔs yu gɛt wan ɔ tu pan dɛn tin ya. Bɔt if dɛn sik ya kɔntinyu fɔ pas tu wiks, i go fayn fɔ mek yu go to dɔktɔ ɛn chɛk yu.

Wetin mek HCC kansa kin kam? Wetin na di tin dɛn we kin mek pɔsin gɛt dis sik?

Bɔrku pipul dɛm wae dɛn no se gɛt HCC (lɛk 80%) gɛt sirosis. Sɔm pipul dɛn kin gɛt dis kansa bifo dɛn gɛt sirosis. Insay dɛn kɔndishɔn ya, if dɛn nɔ trit am, di inflamɛns we nɔ de dɔn na di liva kin mek di liva gɛt siriɔs skata, we kin mek i gɛt HCC.

Bɔku impɔtant tin dɛn de we kin mek yu gɛt mɔ chans fɔ gɛt HCC kansa.

Risk factor Aw dis kin afɛkt?
Epataytis B infεkshכn Wan vayral infεkshכn de spre tru di bכdi wata. Di spɛshal tin bɔt dis na dat i kin mek HCC kansa ivin bifo sirosis apin.
Epataytis C infεkshכn Wan vayral infεkshכn we de spre tru di blɔd. Dis kin pwɛl di liva bak ɛn i kin mek pɔsin gɛt kansa mɔ ɛn mɔ.
Fat liva sik (MASLD) . Fat we nɔ want fɔ gɛda na di liva. Dis risk kin pasmak if yu gɛt fat, mɛtabolik sindrom, ɔ tayp 2 dayabitis.
Fɔ drink rɔm pasmakAlkol na tin we at fɔ mek wi liva swɛla. If yu drink pasmak fɔ lɔng tɛm, dat kin pwɛl yu liva, ɛn dis kin mek yu gɛt sirosis ɛn kansa na yu liva.

If yu de na dis risk grup, yu dɔktɔ go de chɛk yu ɔltɛm fɔ si if yu gɛt sayn dɛn fɔ dis kansa. Dis kin ɛp fɔ no di sik kwik kwik wan ɛn trit am. Yu dɔktɔ go ɛp yu bak fɔ stɔp fɔ smok ɔ drink rɔm, ɛn fɔ kɔntrol sik dɛn we nɔ de mɛn lɛk epataytis infɛkshɔn ɛn dayabitis.

Aw dɛn kin no dis sik kɔrɛkt wan?

We yu go to dɔktɔ, i go fɔs chɛk yu bɔdi ɛn aks yu bɔt di sayn dɛn we yu gɛt, di mɛdikal istri, ɛn aw yu de liv yu layf. Dɔn, dɛn kin du bɔku tɛst fɔ no if dɛn gɛt di sik, lɛk:

  • Blɔd tɛst: Dɛn go chɛk yu blɔd fɔ si if yu gɛt sayn dɛn fɔ gɛt kansa. spεshal wan, dεn go chεk di lεvεl fכ wan protin we dεn kכl alfa-fεtoprotein (AFP) . If dis lɛvɛl go ɔp, i kin bi sayn fɔ HCC ɔ wan kɔndishɔn we kin mek pɔsin gɛt am, lɛk epataytis ɔ sirosis.
  • Imej skan: Skan lɛk ɔltra saund, kɔmpyuta tomografi (CT) skan, magnɛtik rɛsɔnans imej (MRI) , ɔ angiografi kin sho klia wan di kwaliti dɛn we di tumbu ɔ di tɔŋ dɛn we de insay di liva gɛt.
  • Liva bayɔpsi: Sɔntɛnde, if di skan rizɔlt nɔto inof infɔmeshɔn, di dɔktɔ go tek wan rili smɔl tisu frɔm di liva tumbu ɛn chɛk am ɔnda maykroskɔp fɔ si if ɛni kansa sɛl de. Bɔt wan pan di spɛshal tin dɛn we HCC gɛt na dat if yu si di tumbu klia wan pan MRI ɔ CT skan fɔ pɔsin we gɛt sirosis, dɛn kin no di sik we dɛn nɔ tek bayɔpsi .

Wetin na di tritmɛnt dɛm fɔ HCC?

Di tritmɛnt fɔ HCC dipen pan di stej we di kansa de, di ɔl wɛlbɔdi na di liva, ɛn yu jenɛral wɛlbɔdi. Bɔku men tritmɛnt dɛn de we yu kin gɛt.

Di we aw dɛn kin trit am Wan simpul ɛksplen
ƆpreshɔnDɛn kin du ɛpatektomi (dɛn kin pul di pat pan di liva usay di kansa de) ɔ dɛn kin du liva transplant (liva transplant) . Dis kin bi na di fɔs stej dɛm fɔ di sik.
Ablashɔn tɛrapi di kansa sel dεm kin pwεl bay we dεn de bכn dεm wit bכku כt (maykrowev כ rediofrikyuεns wev) כ we dεn kol pasmak we dεn de yuz spεshal nidul.
Embolization Di blɔd vesel dɛn we de gi blɔd to di tumbu kin blok. Sɔntɛnde dɛn kin sɛn mɛrɛsin dɛn we de fɛt kansa (chemoembolization) ɔ smɔl smɔl redioaktiv sid dɛn (redioemboliization) tru dɛn wan ya.
Redyushɔn tɛrapi Smɔl tumbu dɛn we dɛn nɔ go ebul fɔ pul bay ɔpreshɔn, dɛn kin pwɛl dɛn bay we dɛn de yuz raytin we gɛt bɔku ɛnaji. SBRT (Stereotactic body radiation therapy) na spɛshal we we dɛn kin yuz fɔ dis.
Imyunotɛrapi Wi de gi drɔgs we de mek wi bɔdi in yon imyun sistɛm wok, we de mek i no ɛn atak di kansa sɛl dɛn.
Targeted therapy Dɛn kin gi spɛshal mɛrɛsin dɛn we de blok di sayn dɛn we de mek di kansa sɛl dɛn gro ɛn sheb.

Yu dɔktɔ kin tɛl yu bak fɔ tek pat pan klinik trial dɛn we de tɛst nyu tritmɛnt dɛn. Dɛn kin gi yu bak palliative care fɔ ɛp fɔ kɔntrol di sayn dɛm, fɔ ridyus yu diskɔmfɔt, ɛn mek yu layf izi.

Yu tink se dɛn go ebul fɔ mɛn dis sik kpatakpata?

Ɔpreshɔn fɔ pul di tumbu ɔ fɔ transplant di liva na di bɛst tin fɔ mek i wɛl kɔmplit wan. Ivin if i nɔ pɔsibul fɔ mek yu du ɔpreshɔn, ɔda tritmɛnt dɛn de we go mek yu nɔ gɛt di sik, mek di kansa nɔ gro sloslo, ɛn ɛp yu fɔ liv lɔng.

Akɔdin to sɔm statystik, di fayv ia sɔvayv rɛt fɔ pipul dɛm wae gɛt dis sik na 21% nɔmɔ. Bɔt nɔ mek yu fred fɔ dis. Dis nɔto di sem tin fɔ ɔlman. E kin difrɛn bad bad wan fɔ yu sik, aw yu gɛt di kansa, aw yu liva gɛt wɛl bɔdi, ɛn aw yu de du tritmɛnt. Ɛni sikman difrɛn. So, na yu dɔktɔ nɔmɔ go ebul fɔ gi yu di bɛst aidia bɔt wetin fɔ ɛkspɛkt bay di sik we yu gɛt.

Wetin wi kin du fɔ mek wi nɔ gɛt HCC kansa?

Bɔrku tin de wae yu kin du fɔ ridyus yu risk fɔ gɛt dis kansa:

  • Gɛt di vaysin agens Epataytis B. If yu dɔn ɔlrɛdi gɛt di sik, go de chɛk yu ɔltɛm wit dɔktɔ.
  • If yu tink se yu dɔn gɛt Epatitis C, go to dɔktɔ wantɛm wantɛm. Dis na sik we dɛn kin mɛn naw wit mɛrɛsin.
  • Kɔntrol kɔndishɔn dɛn we gɛt fɔ du wit fat liva sik (MASLD). I rili impɔtant fɔ kɔntrol yu bɔdi wet bay we yu de it fayn ɛn ɛksesaiz.
  • Nɔ drink rɔm pasmak kpatakpata.
  • If yu de smok, stɔp wantɛm wantɛm.

Ustɛm a fɔ go to dɔktɔ? Us kwɛstyɔn dɛn a fɔ aks?

If yu gɛt de sik wae wi dɔn tɔk bɔt fɔ pas tu wiks, ɔr if yu sik de wɔs, go to dɔktɔ kwik kwik wan. If yu de na grup we gɛt prɔblɛm, nɔ skip di tɛst dɛn we yu dɔktɔ tɛl yu fɔ du. Mɛmba se, di mɔ we dɛn no dis sik kwik kwik wan, na di mɔ i go izi fɔ mek dɛn trit am fayn.

Na sɔm impɔtant kwɛstyɔn dɛn we yu fɔ aks yu dɔktɔ:

* Aw mi liva de wok fayn?

* Us stej mi kansa de insay?

* Yu tink se dis kin mɛn kpatakpata?

* Us tritmɛnt dɛn a gɛt?

* Wetin na di bad tin dɛn we kin apin to ɛni tritmɛnt?

* Aw tritmɛnt go afɛkt mi ɛvride layf?

* Aw wi go no if di tritmɛnt de wok fayn?

Na nɔmal tin fɔ fil frayd, wɔri, ɛn kɔnfyus we yu lan bɔt siriɔs sik lɛk HCC. Bɔt nɔto yu wan de na dis waka. Ɔndastand yu tritmɛnt dɛm ɛn di sayd ɛfɛkt dɛm we dɛn kin gɛt. Tɔk opin wan wit yu famili, padi dɛn, ɛn dɔktɔ. Dis kin tranga fɔ waka, bɔt if yu no di rayt tin, sɔpɔt yu, ɛn trit yu, yu go ebul fɔ bia wit di prɔblɛm.

Mɛsej we dɛn kin kɛr go na os

  • Epatocellular carcinoma (HCC) na di kayn kansa we de kכmכn pas כl εn we de gro fast fast.
  • Dis sik kin apun bɔrku tɛm pan pipul dɛm wae dɔn ɔlrɛdi gɛt liva sik, mɔr lɛk sirosis.
  • Yu fɔ no bɔt di sayn dɛm lɛk fɔ ebi ɔnda yu rayt rib, fɔ gɛt janda, fɔ swel na yu bɛlɛ, ɛn fɔ lɛf fɔ it bɔku bɔku it. If dɛn tin ya de fɔ pas tu wiks, go to dɔktɔ.
  • Epataytis B/C, fɔ drink pasmak, ɛn fɔ gɛt fat liva sik (MASLD) na di men tin dɛn we kin mek pɔsin gɛt dis sik.
  • If dɛn no di sik kwik kwik wan, dɛn kin ebul fɔ wɛl kɔmplit wan bay we dɛn du ɔpreshɔn ɔ transplant di liva.
  • If yu gɛt ɛni dawt ɔ kwɛstyɔn bɔt dis, nɔ ɛva ignore am. I rili impɔtant fɔ tɔk to yu dɔktɔ opin wan.

Hepatocellular Carcinoma, HCC, liva kansa Sinhala, Sirosis, Epataytis B, Liva simptom dɛm

Frequently Asked Questions (FAQ)

Aw kɔmɔn dis kansa?

Tink bɔt dis: 85 to 90 pan 100 praymari kansa dɛn na di liva na HCC. (We kansa pas ɔdasay na di liva, wi kin kɔl am mɛtastatik kansa.) Na di nɔmba siks kansa we dɛn kin gɛt pas ɔl na di wɔl ɛn na di tɔd tin we kin mek pipul dɛn day wit kansa.

⚠️ Important: The medical articles and information on Nirogi Lanka are for general awareness only, and are by no means a substitute for professional medical advice, diagnosis, or treatment. For any medical problem you have, consult a qualified physician immediately.

💬 Comments (0)

No kɔmɛnt nɔ de yet. Ad yu kɔmɛnt ya fɔ di fɔs tɛm.

Ad yu kɔmɛnt

Duya kɔlkul: 3 + 7 =